Cargando…
The Tie2-agonist Vasculotide rescues mice from influenza virus infection
Seasonal influenza virus infections cause hundreds of thousands of deaths annually while viral mutation raises the threat of a novel pandemic strain. Antiviral drugs exhibit limited efficacy unless administered early and may induce viral resistance. Thus, targeting the host response directly has bee...
Autores principales: | Sugiyama, Michael G., Armstrong, Susan M., Wang, Changsen, Hwang, David, Leong-Poi, Howard, Advani, Andrew, Advani, Suzanne, Zhang, Haibo, Szaszi, Katalin, Tabuchi, Arata, Kuebler, Wolfgang M., Van Slyke, Paul, Dumont, Dan J., Lee, Warren L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457136/ https://www.ncbi.nlm.nih.gov/pubmed/26046800 http://dx.doi.org/10.1038/srep11030 |
Ejemplares similares
-
The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury
por: Rübig, Eva, et al.
Publicado: (2016) -
The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis
por: Kümpers, Philipp, et al.
Publicado: (2011) -
Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice
por: Lask, Aina, et al.
Publicado: (2022) -
Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2
por: Wu, Florence TH, et al.
Publicado: (2015) -
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
por: Gutbier, Birgitt, et al.
Publicado: (2017)